Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Evaluation of the JUICE HA® as an Anti-sarcopenia

Authors not listed

China Medical University Hospital · 2025

Abstract

This study plans to recruit 60 participants aged 65 years and older who have been diagnosed with sarcopenia by a physician. Participants will be randomly assigned into JUICE HA® supplement and placebo group. All of the participants will be asked to take 15 mL/day of JUICE HA® supplement or placebo group for 12 weeks. The aim of this trial is to evaluate the potential of JUICE HA® to enhance physiological status (muscle mass and functional fitness) and to improve the quality of life in patients with sarcopenia.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-05 MST

Cite this

APA
Anonymous. (2025). Evaluation of the JUICE HA® as an Anti-sarcopenia. <em>China Medical University Hospital</em>. https://clinicaltrials.gov/study/NCT06950125
Vancouver
Anonymous. Evaluation of the JUICE HA® as an Anti-sarcopenia. China Medical University Hospital. 2025.
BibTeX
@misc{anon2025Evalua, title = {Evaluation of the JUICE HA® as an Anti-sarcopenia}, author = {Anonymous}, journal = {China Medical University Hospital}, year = {2025}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings